Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast Track designation, in advanced ovarian cancer- ...
Q1 2026 Earnings Call May 14, 2026 8:00 AM EDTCompany ParticipantsWina Huang - Head of Investor RelationsShawn Qu - ...
Global Commercial Footprint -- Over 175 active sites are currently using ClearPoint technology, with expectations to surpass ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results